Form 4: Pfizer CEO Albert Bourla Executes Stock Appreciation Rights, Adjusts Holdings
SEC Form 4 Filing
Pfizer's CEO, Albert Bourla, exercised stock appreciation rights and adjusted his holdings of Pfizer common stock on February 23, 2024.
Summary
- On February 23, 2024, Albert Bourla, the Chairman and CEO of Pfizer Inc., executed stock appreciation rights, resulting in changes to his beneficial ownership of Pfizer common stock.
- The transaction involved the earn-out of 127,674 stock appreciation rights at a price of $27.34.
- A portion of the shares were withheld to satisfy tax obligations (8,831 shares at $27.76) and to cover the exercise price of the stock appreciation rights (103,178 shares at $27.37).
- Following these transactions, Bourla directly owns 327,739 shares of Pfizer common stock and indirectly owns 4,750 shares through a Rule 16b-3 plan.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It provides transparency into the transactions of company insiders.
Comparison to Industry Standards
- Executive compensation packages often include stock options, restricted stock units, and stock appreciation rights to align management's interests with those of shareholders.
- Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring compliance with SEC regulations.
- The details of the stock appreciation rights settlement, including the use of a 20-day average closing price, are typical features of such agreements.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects changes in the CEO's holdings, which are already factored into market perceptions.
- The withholding of shares for tax obligations and exercise price has no material impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Date of the earliest transaction: earn-out of stock appreciation rights, withholding of shares for tax obligations and exercise price. |
| 02/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.